Clinical Trials Logo

Inflammation clinical trials

View clinical trials related to Inflammation.

Filter by:

NCT ID: NCT02239744 Completed - Inflammation Clinical Trials

Intervention Study on the Health Impact of Air Filters in Chinese Adults

Start date: September 2014
Phase: N/A
Study type: Interventional

This study aimed to evaluate whether a short-term indoor air purifier intervention improves cardiopulmonary health based on a randomized double-blind crossover trial

NCT ID: NCT02238028 Not yet recruiting - Inflammation Clinical Trials

Intervention Study on the Health Effects of Wearing Particulate Filtering Respirators

Start date: November 2014
Phase: N/A
Study type: Interventional

An intervention study to assess the cardiovascular and respiratory effects of reducing personal air pollution exposure by wearing particulate filtering respirators.

NCT ID: NCT02236533 Completed - OBESITY Clinical Trials

Healthy Effects of an Innovative Probiotic Pasta

SFLABPASTA
Start date: March 2014
Phase: N/A
Study type: Interventional

The aim of the project was the evaluation of the antioxidant and anti-inflammatory effects of a whole grain pasta, enriched in barley β-glucans and fortified with strains of Bacillus coagulans, versus a control wheat pasta on healthy volunteers, using a parallel randomized controlled trial.

NCT ID: NCT02235714 Completed - Asthma Clinical Trials

Exhaled Breath Condensate Biomarkers of Inflammation in Individuals With Chronic Cervical Spinal Cord Injury

Start date: July 2009
Phase: N/A
Study type: Observational

The purpose of this study is to obtain markers of airway inflammation from the exhaled breath condensate (the moisture in exhaled air) for comparison to blood based markers. These markers will be compared in tetraplegic, asthmatic and able-bodied control groups. Additionally, lung function testing will be performed, and the associations between breath condensate and blood markers and pulmonary function explored between groups.

NCT ID: NCT02235272 Completed - Pain Clinical Trials

Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

Start date: September 2014
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the clinical efficacy and safety of XG-102 (900µg) compared to vehicle in the treatment of subjects with inflammation and pain following cataract surgery.

NCT ID: NCT02233868 Completed - Clinical trials for Alcohol Use Disorder (AUD)

Brain Inflammation and Function in Alcoholism

Start date: February 19, 2015
Phase: Early Phase 1
Study type: Interventional

Background: - Brain inflammation due to high alcohol intake may affect thinking, memory, and concentration. Researchers want to measure this using positron emission tomography (PET). Objective: - To study how excessive alcohol consumption affects brain function. Eligibility: - Adults 30-75 years old who are moderate or severe alcohol drinkers. - Healthy volunteers. Design: - Participants will be screened with medical history, physical exam, interview, and blood and urine tests. Their breath will be tested for alcohol and recent smoking. - Phase 1: - Participants will stay in the hospital 3 days. They will have blood and heart tests and daily urine tests. - A small plastic tube will be inserted by needle in each arm. One will go in a vein, the other in an artery. - Participants will have 2 PET scans with 2 different radioactive compounds. Participants will lie on a bed that slides in and out of the scanner with a cap on their head. - Participants will have magnetic resonance imaging (MRI) scans. Participants will lie in the scanner either resting with their eyes open or while performing an attention task. - Participants will have tests of memory, attention, concentration, and thinking. They may answer questions, take tests, and perform simple actions. - Phase 2 of the study will only be done if Phase 1 results show brain inflammation. - Phase 2 will repeat Phase 1. - For healthy volunteers, Phase 2 will begin 3 weeks after Phase 1. - Other volunteers must not have alcohol for at least 3 weeks and stay in a hospital up to 4-6 weeks between Phase 1 and Phase 2. After Phase 2, they will have 5 follow-up calls over 3 months.

NCT ID: NCT02233231 Completed - Asthma Clinical Trials

Smoking Young Asthmatics: Change of Inflammation During Tobacco Cessation and Steroid Treatment

Start date: August 2011
Phase: Phase 4
Study type: Interventional

This is a study describing changes in inflammation of the airways in asthmatics before and after smoking cessation and steroid treatment.

NCT ID: NCT02232113 Completed - Inflammation Clinical Trials

Frequent Dosing of CERA Improves Nutrition and Inflammation in Hemodialysis Patients

Start date: February 2012
Phase: Phase 4
Study type: Interventional

The response of Continuous Erythropoietic Receptor Activator (CERA) with different dose interval and the survey for influence factors: We aim to evaluate a better clinical response which can be achieved by different dosing interval of a fixed dose of CERA. We expect this study can determine the dosing schedule with better clinical response to CERA and identify the associated factors predicting the cost-effectiveness of CERA in maintenance hemodialysis (HD) patients in Taiwan.

NCT ID: NCT02230345 Completed - Inflammation Clinical Trials

Effects of a Probiotics on the Health of Normal Young Males

FFF
Start date: March 2014
Phase: N/A
Study type: Interventional

The important role played by the GI tract microflora on the metabolic health of an individual are increasingly recognized. In this respect, the initial studies of Metchinkoff that suggested a role of fermented food (specifically yoghourts ) to modulate the gut microflora have evolved into the concept of "probiotics". Probiotics are living microorganisms that bring a benefit to the host when administered in sufficient quantity (WHO/FAO, 2001). Here the investigators will study, in normal young male volunteers, the potential to modulate post-prandial metabolic and inflammatory responses by the administration of a yoghourt containing the probiotic Lactobacillus rhamnosus (LGG).

NCT ID: NCT02229201 Completed - Inflammation Clinical Trials

Comparison of Two Anaesthetics on Brain During Brain Tumour Surgery

Start date: May 2010
Phase: Phase 1
Study type: Interventional

Anaesthesia and surgical stress during craniotomy can lead to brain damage and activation of inflammatory response. Consequently inflammatory cytokines (IL6, IL8, IL10) are released. Cell mediated immune balance can increase postoperative complications (infections, wound healing, multiple organ dysfunction). Many studies have shown that volatile anaesthetics reduce systemic and local inflammatory response during major surgery, but animal studies have shown that volatile anaesthetics can induce neuroinflammation (IL6, NF-κB) that leads to decline of cognitive function in rodent and possible human. Our aim was to investigate how anaesthetic technique for craniotomy influences the release of inflammatory cytokines. Our hypothesis was that when optimal neuroprotective strategies are followed during surgery intravenous anaesthesia attenuates inflammatory response comparing to inhalational anaesthesia. The investigators included 40 patients anaesthetised with remifentanil based anaesthesia with sevoflurane (S group) or propofol (P group). Plasma levels of IL6, IL8, IL10 were measured during preoperative, perioperative and postoperative periods of both groups of patients. The investigators also noted emergence parameters, postoperative (pain, shivering, vomiting) and neurological complications after surgery.